Disease on EC 3.4.24.72 - fibrolase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE 
TITLE OF PUBLICATION
LINK TO PUBMED
Arthritis
Plasminogen is a joint-specific positive- or negative-determinant of arthritis pathogenesis.
Carotid Artery Thrombosis
Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.
Cockayne Syndrome
Involvement of antipain-sensitive protease activity in the interferon-beta-induced UV-refractoriness of Cockayne syndrome fibroblasts.
Infections
Toxoplasma gondii: effects of neuwiedase, a metalloproteinase from Bothrops neuwiedi snake venom, on the invasion and replication of human fibroblasts in vitro.
Lung Injury
Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to murine lungs.
Myocardial Infarction
Defibrase, a purified fibrinolytic protease from snake venom in acute myocardial infarction.
Myocardial Infarction
Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase.
Myocardial Infarction
[Alterations of peripheral blood endothelial progenitor cells from patients with ST elevation myocardial infarction after snake venom fibrinolytic enzyme therapy.]
Myotoxicity
Pathological alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi snake venom.
Neoplasms
The fibrinolysis inhibitor ?2-antiplasmin restricts lymphatic remodelling and metastasis in a mouse model of cancer.
Osteoporosis
Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis.
Pulmonary Embolism
Starase: A bi-functional fibrinolytic protease from hepatic caeca of Asterina pectinifera displays antithrombotic potential.
Reperfusion Injury
Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase.
ST Elevation Myocardial Infarction
[Alterations of peripheral blood endothelial progenitor cells from patients with ST elevation myocardial infarction after snake venom fibrinolytic enzyme therapy.]
Thromboembolism
Improved Reactive Oxygen Species Generation by Chiral Co3 O4 Supraparticles under Electromagnetic Fields.
Thrombosis
Biological and thrombolytic properties of fibrolase--a new fibrinolytic protease from snake venom.
Thrombosis
Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation.
Thrombosis
Clinical utility of novel agents in the treatment of central venous catheter occlusion.
Thrombosis
Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase.
Thrombosis
Extracellular Production of a Potent and Chemically Resistant Nattokinase in Immobilized Escherichia coli Using Response Surface Methodology.
Thrombosis
Feedback regulation of endothelial cell surface plasmin generation by PKC dependent phosphorylation of annexin A2.
Thrombosis
In Vivo Anticoagulant and Thrombolytic Activities of a Fibrinolytic Serine Protease (Brevithrombolase) With the k-Carrageenan-Induced Rat Tail Thrombosis Model.
Thrombosis
Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex.
Thrombosis
Starase: A bi-functional fibrinolytic protease from hepatic caeca of Asterina pectinifera displays antithrombotic potential.
Thrombosis
Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.
Thrombosis
Thrombolytic Potential of Novel Thiol-Dependent Fibrinolytic Protease from Bacillus cereus RSA1.
Venous Thrombosis
Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems.
html completed
